Briefly, in the first stage, PCa candidate biomarkers were discovered by enriching N-linked glycopeptides through SPEG to detect and quantify differentially expressed glycoproteins in the prostate tissue (n = 8) and sera (n = 8) of Pten cKO mice compared to control animals. This evidence concerns the gene PTEN and posterior cortical atrophy.